Yuki Gosei Kogyo Co., Ltd.
Tokyo Stock Exchange 4531.T
Yuki Gosei Kogyo Co., Ltd. EBITDA for the year ending March 31, 2024: USD 12.45 M
-
Yuki Gosei Kogyo Co., Ltd. EBITDA for the year ending March 31, 2023 was USD 11.78 M, a 21.52% change year over year.
-
Yuki Gosei Kogyo Co., Ltd. EBITDA for the year ending March 31, 2022 was USD 9.69 M, a -15.21% change year over year.
-
Yuki Gosei Kogyo Co., Ltd. EBITDA for the year ending March 31, 2021 was USD 11.43 M, a -1.89% change year over year.
-
Yuki Gosei Kogyo Co., Ltd. EBITDA for the year ending March 31, 2020 was USD 11.65 M, a 37.58% change year over year.
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Don’t Miss A Beat
| CEO | Seiichiro Matsumoto |
| IPO Date | Jan. 4, 2001 |
| Location | Japan |
| Headquarters | 10-4, Nihonbashi-Ningyocho 3-chome |
| Employees | 290 |
| Sector | Materials |
| Industries | |
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
Past 5 years
StockViz Staff
February 2, 2025
Any question? Send us an email